bivalirudin
Selected indexed studies
- Bivalirudin in Extracorporeal Membrane Oxygenation. (J Cardiovasc Pharmacol, 2024) [PMID:39259286]
- Bivalirudin in pediatric extracorporeal membrane oxygenation. (Curr Opin Pediatr, 2022) [PMID:35634698]
- Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation. (Perfusion, 2023) [PMID:35616224]
_Worker-drafted node — pending editorial review._
Connections
bivalirudin is a side effect of
Sources
- Bivalirudin in Extracorporeal Membrane Oxygenation. (2024) pubmed
- Bivalirudin in pediatric extracorporeal membrane oxygenation. (2022) pubmed
- Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation. (2023) pubmed
- Bivalirudin. (2008) pubmed
- Bivalirudin. (2026) pubmed
- Bivalirudin during percutaneous coronary intervention in acute coronary syndromes. (2019) pubmed
- Bivalirudin anticoagulation for cardiopulmonary bypass during cardiac surgery. (2025) pubmed
- Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation. (2023) pubmed
- Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation. (2025) pubmed
- Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis. (2024) pubmed